We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+9.78%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$1.13B
AUM Growth
+$120M
Cap. Flow
+$28.7M
Cap. Flow %
2.53%
Top 10 Hldgs %
50.65%
Holding
1,085
New
29
Increased
103
Reduced
134
Closed
31

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.66M
2
AMZN icon
Amazon
AMZN
+$6.92M
3
V icon
Visa
V
+$5.42M
4
MSFT icon
Microsoft
MSFT
+$5.01M
5
DIS icon
Walt Disney
DIS
+$1.76M

Top Sells

Rank Stock Value
1
EWBC icon
East-West Bancorp
EWBC
+$2.12M
2
MRSH
Marsh
MRSH
+$2.09M
3
DAVA icon
Endava
DAVA
+$1.55M
4
AMD icon
Advanced Micro Devices
AMD
+$1.47M
5
NFLX icon
Netflix
NFLX
+$1.29M

Sector Composition

Rank Sector Weight
1 Financials 24.58%
2 Technology 20.68%
3 Consumer Discretionary 16.07%
4 Communication Services 11.68%
5 Healthcare 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBIO icon
1026
Xenetic Biosciences
XBIO
$9.33M
$153 ﹤0.01%
11
KZIA
1027
Kazia Therapeutics
KZIA
$155M
$139 ﹤0.01%
1
UVXY icon
1028
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$276M
0
MNK
1029
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$129 ﹤0.01%
37
CGRN
1030
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$122 ﹤0.01%
40
GALT icon
1031
Galectin Therapeutics
GALT
$405M
$114 ﹤0.01%
40
GCVRZ
1032
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$112 ﹤0.01%
130
ELOX
1033
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
0
GRCE
1034
Grace Therapeutics
GRCE
$44.6M
$74 ﹤0.01%
1
FAZ
1035
Direxion Daily Financial Bear 3x ETF
FAZ
$88.2M
0
CRIS icon
1036
Curis
CRIS
$3.61M
0
SCPX
1037
DELISTED
Scorpius Holdings, Inc.
SCPX
0
CRC
1038
DELISTED
California Resources Corporation
CRC
$45 ﹤0.01%
5
TPST icon
1039
Tempest Therapeutics
TPST
$17.5M
0
GENE
1040
DELISTED
Genetic Technologies Ltd.
GENE
$40 ﹤0.01%
4
GTE icon
1041
Gran Tierra Energy
GTE
$349M
$39 ﹤0.01%
3
BLRX
1042
BioLineRX
BLRX
$11.4M
0
LSTA icon
1043
Lisata Therapeutics
LSTA
$15.2M
$25 ﹤0.01%
1
SDRL
1044
DELISTED
Seadrill Limited Common Stock
SDRL
$23 ﹤0.01%
9
QCLS
1045
Q/C Technologies Inc
QCLS
$19.2M
0
NNVC icon
1046
NanoViricides
NNVC
$31.7M
$20 ﹤0.01%
8
+1
+14% +$2
FTR
1047
DELISTED
Frontier Communications Corp.
FTR
$11 ﹤0.01%
12
MBOT icon
1048
Microbot Medical
MBOT
$99.4M
$10 ﹤0.01%
1
SNOA icon
1049
Sonoma Pharmaceuticals
SNOA
$6.27M
0
OIBR.C
1050
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$4 ﹤0.01%
4

Similar funds

RBC Europe's Q4 2019 Portfolio in Review

As of Q4 2019, RBC Europe held 1,085 positions worth $1.13B, up 12% from $1.01B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

RBC Europe's Q4 2019 filing shows 29 new, 103 increased, 134 reduced and 31 closed positions. Its largest new stake was Boot Barn: 9,290 shares worth $414K. The largest sale was East-West Bancorp, an estimated $2.12M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

  • RBC Europe's largest Q4 2019 buy was Boot Barn: 9,290 shares worth $414K.
  • RBC Europe added most to Berkshire Hathaway Class B in Q4 2019, an estimated $8.66M increase.
  • RBC Europe's biggest Q4 2019 reduction was Marsh, cutting an estimated $2.09M.
  • RBC Europe fully exited East-West Bancorp in Q4 2019, selling an estimated $2.12M.
  • RBC Europe's ten largest holdings make up 51% of its $1.13B portfolio in Q4 2019.
  • RBC Europe opened 29 new positions and closed 31 in Q4 2019.
  • RBC Europe's portfolio value rose 12% quarter-over-quarter to $1.13B.

Based on RBC Europe's 13F filing for Q4 2019, filed 9 Nov 2023.